Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Introduction | 5 | 1 |
| Global Markets Direct Report Coverage | 5 | 1 |
| Nonstructural Protein 4B (NS4B) Overview | 6 | 1 |
| Therapeutics Development | 7 | 3 |
| Nonstructural Protein 4B (NS4B) Products under Development by Stage of Development | 7 | 1 |
| Nonstructural Protein 4B (NS4B) Products under Development by Therapy Area | 8 | 1 |
| Nonstructural Protein 4B (NS4B) Products under Development by Indication | 9 | 1 |
| Nonstructural Protein 4B (NS4B) Pipeline Products Glance | 10 | 2 |
| Late Stage Products | 10 | 1 |
| Early Stage Products | 11 | 1 |
| Nonstructural Protein 4B (NS4B) Products under Development by Companies | 12 | 2 |
| Nonstructural Protein 4B (NS4B) Therapeutics Assessment | 14 | 6 |
| Assessment by Monotherapy/Combination Products | 14 | 1 |
| Assessment by Mechanism of Action | 15 | 1 |
| Assessment by Route of Administration | 16 | 2 |
| Assessment by Molecule Type | 18 | 2 |
| Nonstructural Protein 4B (NS4B) Companies Involved in Therapeutics Development | 20 | 5 |
| Gilead Sciences, Inc. | 20 | 1 |
| GlaxoSmithKline Plc | 21 | 1 |
| Inovio Pharmaceuticals, Inc. | 22 | 1 |
| Johnson &Johnson | 23 | 1 |
| Merck &Co., Inc. | 24 | 1 |
| Nonstructural Protein 4B (NS4B) Drug Profiles | 25 | 8 |
| GSK-8853 Drug Profile | 25 | 1 |
| INO-8000 Drug Profile | 26 | 2 |
| PTC-512 Drug Profile | 28 | 1 |
| PTC-725 Drug Profile | 29 | 1 |
| PTC-971 Drug Profile | 30 | 1 |
| Small Molecule to Inhibit NS4B for Dengue and Yellow Fever Virus Infections Drug Profile | 31 | 1 |
| Small Molecule to Inhibit NS4B Protein for HCV Drug Profile | 32 | 1 |
| Nonstructural Protein 4B (NS4B) Dormant Projects | 33 | 1 |
| Nonstructural Protein 4B (NS4B) Discontinued Products | 34 | 1 |
| Nonstructural Protein 4B (NS4B) Featured News &Press Releases | 35 | 5 |
| Apr 27, 2016: Inovio Partners with National Cancer Institute and Mayo Clinic to Initiate Hepatitis C Immunotherapy Clinical Trial | 35 | 1 |
| Oct 21, 2013: Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial | 35 | 1 |
| Jan 09, 2013: Inovio Pharma To Initiate Clinical Trial For Hepatitis C Therapeutic Vaccine | 36 | 1 |
| Oct 26, 2009: Wellcome Trust funds dengue fever research in Leuven | 37 | 1 |
| Aug 10, 2009: PTC Therapeutics Announced Achievement Of Major Milestone In Schering-Plough Hepatitis C Collaboration | 38 | 1 |
| Mar 20, 2006: Schering-Plough And PTC Therapeutics Announced Collaboration For Development Of PTC's Preclinical Hepatitis C Compounds | 38 | 2 |
| Appendix | 40 | 2 |
| Methodology | 40 | 1 |
| Coverage | 40 | 1 |
| Secondary Research | 40 | 1 |
| Primary Research | 40 | 1 |
| Expert Panel Validation | 40 | 1 |
| Contact Us | 40 | 1 |
| Disclaimer | 41 | 1 |